Juan Camilo Arjona Ferreira - Mar 1, 2022 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Mar 1, 2022
Transactions value $
-$18,183
Form type
4
Date filed
3/3/2022, 03:54 PM
Previous filing
Jan 6, 2022
Next filing
Apr 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale -$18.2K -1.36K -0.83% $13.35 163K Mar 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.